Physician profile
George E Springer, JR.
NPI 1336240787
$1,003.21
in general payments reported to CMS, 2019-2025
17 companies · $65.99 in 2025
The $65.99 reported for 2025 was more than what 76% of Nutrition providers received nationally (typical 2025 total: $32.02).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.04 · 2020: $17.53 · 2021: $177 · 2022: $394 · 2023: $176 · 2024: $156 · 2025: $65.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $359.50 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $100.44 | 2022-2024 | Zepbound, Jardiance |
| Jazz Pharmaceuticals INC. | $81.73 | 2020-2021 | |
| Novo Nordisk INC | $75.22 | 2022-2023 | Wegovy, Ozempic |
| Amgen INC. | $61.78 | 2021-2022 | |
| Idorsia Pharmaceuticals US INC | $57.27 | 2022-2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $35.92 | 2021-2022 | |
| Exact Sciences Corporation | $33.77 | 2023-2024 | Cologuard Collection Kit |
| Supernus Pharmaceuticals, INC. | $32.38 | 2022 | |
| Abbvie INC. | $25.78 | 2021 | |
| Clarus Therapeutics INC. | $24.04 | 2021 | |
| Sanofi-Aventis U.S. LLC | $23.94 | 2023 | |
| Eisai INC. | $22.50 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.86 | 2022 | |
| Vistapharm, INC. | $17.64 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.04 | 2019 | |
| Acella Pharmaceuticals, LLC | $14.40 | 2023 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.